Literature DB >> 27312444

Silent diabetic nephropathy.

Samar M Said1, Samih H Nasr2.   

Abstract

Moderately increased albuminuria is widely accepted as the first clinical sign of diabetic nephropathy. However, previous morphometric studies and the autopsy study by Klessens et al. have clearly demonstrated that by the time moderately increased albuminuria is evident, the kidneys in some diabetic patients have already undergone glomerular and tubulointerstitial damage, which indicates that it is not a sensitive marker for diabetic nephropathy. Hence, there is a need for new biomarkers of early diabetic nephropathy.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27312444     DOI: 10.1016/j.kint.2016.02.042

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis.

Authors:  Giorgia Comai; Deborah Malvi; Andrea Angeletti; Francesco Vasuri; Sabrina Valente; Francesca Ambrosi; Irene Capelli; Matteo Ravaioli; Gianandrea Pasquinelli; Antonietta D'Errico; Alessia Fornoni; Gaetano La Manna
Journal:  Am J Nephrol       Date:  2019-06-05       Impact factor: 3.754

2.  Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Authors:  Shaomin Shi; Lihua Ni; Ling Gao; Xiaoyan Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

Review 3.  Trajectories of kidney function in diabetes: a clinicopathological update.

Authors:  Megumi Oshima; Miho Shimizu; Masayuki Yamanouchi; Tadashi Toyama; Akinori Hara; Kengo Furuichi; Takashi Wada
Journal:  Nat Rev Nephrol       Date:  2021-08-06       Impact factor: 28.314

Review 4.  Clinico-pathological features of kidney disease in diabetic cases.

Authors:  Kengo Furuichi; Miho Shimizu; Hirokazu Okada; Ichiei Narita; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2018-03-21       Impact factor: 2.801

Review 5.  Comparing the Efficacy of Angiotensin Converting Enzyme Inhibitors with Calcium Channel Blockers on the Treatment of Diabetic Nephropathy: A Meta-Analysis.

Authors:  Zhaowei Zhang; Chunlin Chen; Shiwen Lv; Yalan Zhu; Tianzi Fang
Journal:  Iran J Public Health       Date:  2019-02       Impact factor: 1.429

6.  Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without Nephropathy.

Authors:  Min Sun Choi; Ji Eun Jun; Sung Woon Park; Jee Hee Yoo; Jiyeon Ahn; Gyuri Kim; Sang-Man Jin; Kyu Yeon Hur; Moon-Kyu Lee; Jae Hyeon Kim
Journal:  Diabetes Metab J       Date:  2021-02-02       Impact factor: 5.376

Review 7.  Current updates on protein as biomarkers for diabetic kidney disease: a systematic review.

Authors:  Rani Sauriasari; Dhonna Dwi Safitri; Nuriza Ulul Azmi
Journal:  Ther Adv Endocrinol Metab       Date:  2021-10-27       Impact factor: 3.565

8.  Identification of novel key genes and potential candidate small molecule drugs in diabetic kidney disease using comprehensive bioinformatics analysis.

Authors:  Bin Li; Siyang Ye; Yuting Fan; Yi Lin; Suchun Li; Huajing Peng; Hui Diao; Wei Chen
Journal:  Front Genet       Date:  2022-08-12       Impact factor: 4.772

Review 9.  Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations.

Authors:  Chin Meng Khoo; Chaicharn Deerochanawong; Siew Pheng Chan; Bien Matawaran; Wayne Huey-Herng Sheu; Juliana Chan; Ambrish Mithal; Andrea Luk; Ketut Suastika; Kun-Ho Yoon; Linong Ji; Nguyen Huu Man; Carol Pollock
Journal:  Diabetes Obes Metab       Date:  2020-11-20       Impact factor: 6.577

10.  Midazolam Ameliorates Hyperglycemia-Induced Glomerular Endothelial Dysfunction by Inhibiting Transglutaminase 2 in Diabetes.

Authors:  Jae-Ah Seo; Nilofar Danishmalik Sayyed; Yeon-Ju Lee; Hye-Yoon Jeon; Eun-Bin Kim; Seok-Ho Hong; Soyeon Cho; Minsoo Kim; Kwon-Soo Ha
Journal:  Int J Mol Sci       Date:  2022-01-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.